Search

everythinglearnresearchcommunity

for

Search:↓

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Trichobiolight effectively treats hair loss with 82.5% success.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Personality traits and anxiety affect hair loss patients' quality of life.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Long COVID causes various long-term health issues and needs better awareness and treatment.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

A woman survived a massive lithium overdose that caused a form of hair loss.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.